BridgeMD
New treatment option for Acute Kidney Injury
Official title UPTAKE - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care Hospitalization
ClinicalTrials.gov ID: NCT06537453
What this study is testing
- What it's testing
- Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or death Study Intervention: Multi-component Digital Health Solutions, including: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years old.
- AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17.
- Hospitalization \> 48 hours.
- LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or...
- Meets all of Virtual Home Hospital programs of Calgary and Edmonton zones.
You likely can't join if
- Non-Alberta residents.
- Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs.
- C1 or C2 goals of care.
- Hospitalization \> 30 days.
- Will be discharged to long-term care.
- Kidney failure receiving dialysis.
See the full eligibility criteria
- Age ≥ 18 years old.
- AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17.
- Hospitalization \> 48 hours.
- LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or higher.
- Meets all of Virtual Home Hospital programs of Calgary and Edmonton zones.
- Non-Alberta residents.
- Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs.
- C1 or C2 goals of care.
- Hospitalization \> 30 days.
- Will be discharged to long-term care.
- Kidney failure receiving dialysis.
- Already admitted in Virtual Home Hospital Program
The study team makes the final eligibility decision.
Where it's taking place
- Calgary, Alberta, Canada
- Edmonton, Alberta, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Calgary, Alberta, Canada; Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.